Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

The effect of regular colchicine treatment on biomarkers related with vascular injury in newly diagnosed patients with familial Mediterranean fever.

Sari I, Yuksel A, Kozaci D, Selcuk S, Gokce G, Yildiz Y, Demirel H, Sop G, Alacacioglu A, Gunay N, Akkoc N.

Inflammation. 2012 Jun;35(3):1191-7. doi: 10.1007/s10753-012-9428-7.

PMID:
22258906
2.

Evaluation of circulating endothelial biomarkers in familial Mediterranean fever.

Pamuk BO, Sari I, Selcuk S, Gokce G, Kozaci DL.

Rheumatol Int. 2013 Aug;33(8):1967-72. doi: 10.1007/s00296-013-2681-8. Epub 2013 Jan 29.

PMID:
23358733
3.

Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever.

Kiraz S, Ertenli I, Arici M, Calgüneri M, Haznedaroglu I, Celik I, Pay S, Kirazli S.

Clin Exp Rheumatol. 1998 Nov-Dec;16(6):721-4.

PMID:
9844766
4.

Is Familial Mediterranean Fever a thrombotic disease or not?

Demirel A, Celkan T, Kasapcopur O, Bilgen H, Ozkan A, Apak H, Arisoy N, Yildiz I.

Eur J Pediatr. 2008 Mar;167(3):279-85. Epub 2007 Apr 14.

PMID:
17436016
5.

Plasma levels of soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) in familial Mediterranean fever.

Başar O, Oztürk MA, Köklü S, Ayaz S, Yüksel O, Kiraz S, Ertenli I, Calgüneri M.

Joint Bone Spine. 2007 Jan;74(1):52-5. Epub 2006 Apr 17.

PMID:
17223601
6.

The anemia of familial Mediterranean fever disease.

Celkan T, Celik M, Kasapçopur O, Ozkan A, Apak H, Ocak S, Arisoy N, Yildiz I.

Pediatr Hematol Oncol. 2005 Dec;22(8):657-65.

PMID:
16251171
7.

Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever.

Sari I, Karaoglu O, Can G, Akar S, Gulcu A, Birlik M, Akkoc N, Tunca M, Goktay Y, Onen F.

Clin Rheumatol. 2007 Sep;26(9):1467-73. Epub 2007 Jan 23.

PMID:
17242867
8.

Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): is it early evidence of interaction between inflammation and endothelial dysfunction in FMF?

Terekeci HM, Oktenli C, Ozgurtas T, Nalbant S, Top C, Celik S, Tapan S, Kucukardali Y, Sanisoglu YS, Solmazgul E, Sahan B, Sayan O.

J Rheumatol. 2008 Oct;35(10):2024-9. Epub 2008 Sep 1.

PMID:
18785307
9.

Plasma and platelet serotonin levels in familial Mediterranean fever.

Onat AM, Ozçakar L, Oztürk MA, Uçar G, Ureten K, Dagli N, Kiraz S, Ertenli I, Calgüneri M.

Clin Exp Rheumatol. 2007 Jul-Aug;25(4 Suppl 45):S16-20.

PMID:
17949546
10.

A single testing of serum amyloid a levels as a tool for diagnosis and treatment dilemmas in familial Mediterranean fever.

Berkun Y, Padeh S, Reichman B, Zaks N, Rabinovich E, Lidar M, Shainberg B, Livneh A.

Semin Arthritis Rheum. 2007 Dec;37(3):182-8. Epub 2007 May 23.

PMID:
17512038
11.

Tubular functions in familial Mediterranean fever.

Akkuş S, Calişkan S, Kasapçopur O.

Turk J Pediatr. 2002 Oct-Dec;44(4):317-20.

12.

Selective serotonin reuptake inhibitors reduce the attack frequency in familial mediterranean Fever.

Onat AM, Oztürk MA, Ozçakar L, Ureten K, Kaymak SU, Kiraz S, Ertenli I, Calgüneri M.

Tohoku J Exp Med. 2007 Jan;211(1):9-14.

13.

Serum soluble intercellular adhesion molecule 1 and interleukin 8 levels in familial Mediterranean fever.

Direskeneli H, Ozdogan H, Korkmaz C, Akoglu T, Yazici H.

J Rheumatol. 1999 Sep;26(9):1983-6.

PMID:
10493680
14.

Neutrophil-derived S100A12 as novel biomarker of inflammation in familial Mediterranean fever.

Kallinich T, Wittkowski H, Keitzer R, Roth J, Foell D.

Ann Rheum Dis. 2010 Apr;69(4):677-82. doi: 10.1136/ard.2009.114363. Epub 2009 Sep 17.

PMID:
19762364
15.

QT interval variability in familial Mediterranean fever: a study in colchicine-responsive and colchicine-resistant patients.

Nussinovitch U, Kaminer K, Nussinovitch M, Volovitz B, Lidar M, Nussinovitch N, Livneh A.

Clin Rheumatol. 2012 May;31(5):795-9. doi: 10.1007/s10067-011-1926-8. Epub 2012 Jan 25.

PMID:
22271228
16.

Effect of colchicine on immunoregulatory abnormalities in familial Mediterranean fever.

Schlesinger M, Ilfeld D, Handzel ZT, Altman Y, Kuperman O, Levin S, Bibi C, Netzer L, Trainin N.

Clin Exp Immunol. 1983 Oct;54(1):73-9.

17.

Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever.

Duzova A, Bakkaloglu A, Besbas N, Topaloglu R, Ozen S, Ozaltin F, Bassoy Y, Yilmaz E.

Clin Exp Rheumatol. 2003 Jul-Aug;21(4):509-14.

PMID:
12942707
18.

Mean platelet volume in children with familial Mediterranean fever.

Makay B, Türkyilmaz Z, Unsal E.

Clin Rheumatol. 2009 Aug;28(8):975-8. doi: 10.1007/s10067-009-1148-5. Epub 2009 Mar 13.

PMID:
19283330
19.

Colchicine treatment in children with familial Mediterranean fever.

Ozkaya N, Yalçinkaya F.

Clin Rheumatol. 2003 Oct;22(4-5):314-7.

PMID:
14579163
20.

Vitamin B12 levels in familial Mediterranean fever patients treated with colchicine.

Gemici AI, Sevindik ÖG, Akar S, Tunca M.

Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):57-9. Epub 2013 Sep 9.

PMID:
24064015
Items per page

Supplemental Content

Write to the Help Desk